Friday, May 24, 2024

LATYPOVA: This means that, for practical purposes, there is no private biopharmaceutical manufacturing industry in the U.S. It is all controlled by the government and specifically, by the DOD

 A very good read, I was extensively quoted in this article: childrenshealthdefense.org/defender/bill-

Latypova told The Defender that “mRNA is entirely funded and pushed on the market under military contracts and funding. It is represented as ‘defensive’ activity [to] skirt the Bioweapons Convention, [1975] which prohibits making offensive bioweapons.” According to Latypova, “The Pentagon came up with the cover story of ‘pandemic preparedness’ [to] fund on a large scale the making of biological poisons and related systems, including making them at scale.” As a result of this research, Gates has invested in companies actively pursuing mRNA technology — and continues to invest in those companies today. "“In 2020-2021, DOD spent $50 billion funding COVID products alone. This represents approximately 50% of the entire U.S. pharmaceutical industry spending on R&D per year. This means that, for practical purposes, there is no private biopharmaceutical manufacturing industry in the U.S. It is all controlled by the government and specifically, by the DOD,” Latypova said. Latypova told The Defender that, “mRNA technology can get around the Bioweapons Convention restrictions because it is a synthetic chemical drug, not a live pathogen.” Live pathogens are banned under the convention. Latypova also highlighted the role of Col. Matt Hepburn of DARPA, who she said helped mastermind the COVID-19 “pandemic preparedness and response” and DOD linkages with Big Pharma years before the pandemic."

No comments:

Post a Comment